Two-year outcomes of endovascular therapy for femoropopliteal arterial lesions for patients with high bleeding risk
Yuki Shima(Kurashiki Central Hospital), Kazushige Kadota(Kurashiki Central Hospital), Kazunori Mushiake(Kurashiki Central Hospital), Akihiro Ikuta(Kurashiki Central Hospital), Narumi Taninobu(Kurashiki Central Hospital), Hiroyuki Tanaka(Kurashiki Central Hospital)
Cited by 7
Related Papers
Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation
|Circulation|2009|358
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome
|JAMA Cardiology|2022|313
Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent
|Journal of the American College of Cardiology|2013|204
Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores
|Journal of the American Heart Association|2018|198